Unexpected uptake of gadoxetic acid in a hepatic metastasis from T-cell lymphoma

Cancer Imaging

Volumn 12, Issue 1, 2012, Pages 122-125

  Song, Won S ^a   Schwope, Ryan B ^a   Taylor, Kenneth A ^a   Lisanti, Christopher J ^a  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

Gadoxetic acid; Liver; Magnetic resonance imaging; Metastases; T cell lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOXETIC ACID;

ADULT; ARTICLE; BACKACHE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER INJURY; LIVER METASTASIS; LIVER PARENCHYMA; LYMPHADENOPATHY; MALE; MEDIASTINUM MASS; NUCLEAR MAGNETIC RESONANCE IMAGING; T CELL LYMPHOMA;

BACK PAIN; BIOPSY, FINE-NEEDLE; CONTRAST MEDIA; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GADOLINIUM DTPA; HUMANS; LEUKEMIC INFILTRATION; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEDIASTINUM; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RADIOPHARMACEUTICALS; YOUNG ADULT;

EID: 84862175186     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2012.0020     Document Type: Article

References (11)

1. Lee WK, Lau EW, Duddalwar VA, et al. Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings. AJR Am J Roentgenol 2008; 191: 198-206. doi:10.2214/AJR.07.3146. (Pubitemid 351955189)
2. Kaneko K, Nishie A, Arima F, et al. A case of diffuse-type primary hepatic lymphoma mimicking diffuse hepatocellular carcinoma. Ann Nucl Med 2011; 25: 303-307. doi:10.1007/s12149-010-0460-0.
3. Fidler J, Hough D. Hepatocyte-specific magnetic resonance imaging contrast agents. Hepatology 2011; 53: 678-682. doi:10.1002/hep.24158.
4. Ringe KI, Husarik DB, Sirlin CB, et al. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 2010; 195: 13-28. doi:10.2214/AJR.10. 4392.
5. Goshima S, Kanematsu M, Watanabe H, et al. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR Am J Roentgenol 2010; 195: 941-946. doi:10.2214/AJR.09.3730.
6. Lee NK, Kim S, Lee JW, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 2009; 29: 1707-1724. doi:10.1148/rg. 296095501.
7. Stern W, Schick F, Kopp AF, et al. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. Acta Radiol 2000; 41: 255-262. doi:10.1080/ 028418500127345208.
8. Cruite I, Schroeder M, Merkle EM, et al. Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 2010; 195: 29-41. doi:10.2214/AJR.10.4538.
9. Cortelazzo S, Ponzoni M, Ferreri AJ, et al. Lymphoblastic lymphoma. Crit Rev Oncol/Hematol 2011; 79: 330-343. doi:10.1016/j.critrevonc.2010.12.003.
10. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at Gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 2005; 234: 468-478. doi:10.1148/radiol.2342040278. (Pubitemid 40139918)
11. Grazioli L, Morana G, Federle MP, et al. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001; 221: 731-739. doi:10.1148/radiol.2213010139. (Pubitemid 33101765)